ulcerative-colitis

Documents about ulcerative-colitis

• Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis#832973ClinicalTrials.gov
• Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative Colitis#838928ClinicalTrials.gov
• Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients#861687ClinicalTrials.gov
• Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)#862038ClinicalTrials.gov
• Effects of Exercise in Patients With Ulcerative Colitis#870221ClinicalTrials.gov
• Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis#980523ClinicalTrials.gov
• A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)#1009356ClinicalTrials.gov
• The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis#802282ClinicalTrials.gov
• Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis#804770ClinicalTrials.gov
• ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery#842742ClinicalTrials.gov
• A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis#843554ClinicalTrials.gov
• A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease#848290ClinicalTrials.gov
• A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice#850573ClinicalTrials.gov
• Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis#877309ClinicalTrials.gov
• An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese Patients#878957ClinicalTrials.gov
• A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis#894056ClinicalTrials.gov
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)#898657ClinicalTrials.gov
• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)#899069ClinicalTrials.gov
• Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis#980552ClinicalTrials.gov
• Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study#983950HAL (France)
• LIAISON ® Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study#983953HAL (France)
• Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis#1044190ClinicalTrials.gov
• The Promotion Plan of Moxibustion on Ulcerate Colitis#846610ClinicalTrials.gov
• Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers#152435ClinicalTrials.gov
• Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population#800684ClinicalTrials.gov
• A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis#835984ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis#839124ClinicalTrials.gov
• Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)#858654ClinicalTrials.gov
• Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)#873699ClinicalTrials.gov
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)#877398ClinicalTrials.gov
• Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis#983873HAL (France)
• Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study#983947HAL (France)
• An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase#1045989ClinicalTrials.gov
• Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study#311951HAL (France)
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)#833495ClinicalTrials.gov
• A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease#839535ClinicalTrials.gov
• Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in Switzerland#864335ClinicalTrials.gov
• A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis#898493ClinicalTrials.gov
• A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies#873916ClinicalTrials.gov
• Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis#874970ClinicalTrials.gov
• Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis#899065ClinicalTrials.gov
• Management of Patients with Ulcerative Proctitis: a Global Survey#268711HAL (France)
• TP0502-Pharmaco-Scintigraphic-Study and Amendment#892476ClinicalTrials.gov
• First-line biologic therapy selection highly impacts ulcerative colitis outcomes: results from the APPETISER study#398713HAL (France)
• Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis Patients over and under 65 Years of Age: A Real-World Comparative Analysis#477059OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy#624873HAL (France)
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)#810317ClinicalTrials.gov
• The Fecal Immunoassay Occult Blood Test Combined With Calprotectin Sequential Linkage Imaging Endoscopy Screening Strategy for Monitoring Tumor Changes Associated With Long-duration Ulcerative Colitis#827321ClinicalTrials.gov
• Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)#833577ClinicalTrials.gov
• A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease#895215ClinicalTrials.gov